USAID Broad Agency Announcement for Global Health Challenges

USAID Broad Agency Announcement for Global Health Challenges is sponsored by United States Agency for International Development (USAID). USAID invites applicants to co-create, co-design, co-invest, and collaborate in the research, development, piloting, testing, and scaling of innovative, practical, and cost-effective interventions to address pressing problems in global health.

This broad announcement can encompass digital health AI solutions for clinical decision support in global health contexts like Kenya and Somalia.

GHTC applauds USAID's continued prioritization of global health innovation through new BAA country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, Democratic Republic of the Congo Cook Islands Costa Rica Cote D'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kosovo Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Barthelemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Serbia and Montenegro Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.s. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe By submitting this form, you are agreeing to the data-use policies outlined in this privacy notice.

GHTC applauds USAID's continued prioritization of global health innovation through new BAA GHTC applauds USAID's continued prioritization of global health innovation through new BAA GHTC welcomes the US Agency for International Development’s (USAID’S) release of a broad agency announcement (BAA) seeking proposals to develop novel tools and approaches to advance global health.

We are pleased to see the agency's continued commitment to health research and development (R&D) and its interest in working with partners in low- and middle-income countries. For decades, USAID has invested in R&D for new vaccines, drugs, diagnostics, and other tools as part of its mission to advance global health.

Unfortunately, in recent years, USAID investments in R&D have not kept pace with total global health spending—a trend that limits the agency’s ability to deliver the tools needed to defeat both long-standing and emerging health challenges.

We hope this BAA will increase total funding for R&D efforts and fulfill the congressional directive in the fiscal year 2023 omnibus package that USAID increase its investments in global health R&D over the prior year. The opportunity presented by this BAA aligns with GHTC’s nonpartisan policy analysis recommending that a dedicated R&D funding line be created for USAID with no less than US$250 million in additive funding.

Such an influx of new research funding would supercharge USAID’s innovation capacity, help close the biggest gaps in our global health toolbox, and save more lives more quickly.

Other news articles you may like: GHTC joins letter urging Congress to advance PASTEUR Act for AMR R&D GHTC endorses SUPER BUGS Act to improve global research coordination GHTC endorsed and provided input to Representative Mike Levin's office for the Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy (SUPER BUGS) Act. The press release includes a quite from Jamie Bay Nishi, GHTC executive director.